- Home » News and Events
NEWS & EVENTS
NEWS & EVENTS
Our newest offerings and capabilities. Recent investments in network capacity, new and expanded services and expertise. Upcoming conferences and events.
Catalent Appoints Charles Lickfold as Chief Information Officer
Jun 2, 2020
Catalent today announced the appointment of Charles Lickfold as Senior Vice President, Chief Information Officer. Mr. Lickfold succeeds John McGill, who plans to retire in September 2020.
Catalent Announces Acquisition of Japanese Facility to Provide Local and Global Clinical Supply Solutions
May 21, 2020
Catalent announced a deal to acquire a clinical packaging facility in Minakuchi, located in the Shiga prefecture of Japan, from Teva-Takeda Pharmaceuticals, Nagoya Aichi, Japan.
Catalent to Present Assessment Methods and Design Approaches for T-Cell Manufacturing Challenges at ISCT 2020 Virtual
May 20, 2020
Catalent today announced that Jean-François Chaubard, Senior Director, Open Innovation at Catalent Cell & Gene Therapy, will be presenting at the ISCT 2020 Paris Virtual conference.
Triphase Accelerator and Catalent Announce Interim Results of a Dose Escalation Phase 1 Clinical Trial of TRPH-222 in Patients with Non-Hodgkin’s Lymphoma
May 18, 2020
Triphase Accelerator and Catalent today announced interim results for Triphase Accelerator’s multi-center, open-label, monotherapy study of TRPH-222 in heavily pre-treated patients with relapsed and/or refractory B-cell lymphoma.
Proactive Strategies to Avoid Supply Delays to be Presented by Catalent at Outsourcing in Clinical Trials Virtual Conference
May 14, 2020
Catalent today announced that it will present at the upcoming conference, ‘Outsourcing in Clinical Trials 2020 – A Virtual Experience’.
ABC News Nightline Features Catalent Bloomington Site in National Segment
May 13, 2020
ABC News Nightline sat down with Catalent, and other manufacturing companies, to discuss their contributions to the fight against COVID-19.
Catalent Signs Development Agreement with Ennaid Therapeutics on its COVID-19 Lead Program
May 13, 2020
Catalent today announced a collaboration with Ennaid Therapeutics to develop an oral, antiviral treatment targeted at COVID-19.
Catalent Responds to the Global Outbreak of COVID-19
May 13, 2020
As a development and manufacturing partner that supplies medicines, clinical trial materials, and health products to patients and consumers, we are taking action to minimize the impact of the COVID-19 pandemic.
Catalent Partners with Humanigen to Support FDA-Approved Phase 3 Lenzilumab Study for COVID-19
May 7, 2020
Catalent today welcomed the news by Humanigen, Inc., that it has dosed the first COVID-19 patient in its previously announced Phase 3 study for lenzilumab.
BIO Digital
Date: June 8-11, 2020
BPI Theater at BIO Digital
Date: June 8-11, 2020
Endpoints at BIO Digital
Date: June 9, 2020
Webinar: Based on Exclusive Survey: Bioavailability Enhancement – Industry Insights, Key Challenges & Advanced Development Solutions
Date: June 16, 2020
Webinar: Clinical Readiness – Practical and Innovative Solutions for AAV Development and Manufacturing
Date: June 23, 2020
Controlled Release Society Annual Meeting (Virtual Conference)
Date: June 27 – July 1, 2020
One Nucleus ON Helix Digital
Date: July 14, 2020
DIA China
Date: July 29 – August 1, 2020
World Orphan Drug Congress
Date: August 24-26, 2020
GCSG US Conference
Date: August 30 – September 2, 2020
PEGS Boston
Date: August 31- September 4, 2020
Vitafoods Europe
Date: September 1–3, 2020
CPHI NA
Date: September 9-11, 2020
PBSS – Regulated Large Molecule Bioanalysis: Fundamentals, the New FDA Guidance and Beyond
Date: September 17, 2020
BioProcess International
Date: September 21-24, 2020
Natural Products Expo East
Date: September 23-26, 2020
World Vaccine Congress
Date: September 27-29, 2020
NYSCC Suppliers’ Day
Date: September 30 – October 1, 2020